TBRG

NEUTRALM&A

TruBridge, Inc.

2026-07-01

Price

$26.23

+0.08%

This is the 2026-07-01 snapshot — the signals and analysis for TBRG as of this single trading day.

View full TBRG research hub →

Score13.0Top Tier

Signals5/8 DNA1/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume1.2xvs 20d avg

Analysis

TruBridge's price action is entirely dictated by its pending $557 million all-cash acquisition by IKS Health at $26.25 per share. This definitive buyout explains the stock's QUIET_STORM and STEADY_CLIMB signals, as merger arbitrageurs pin the price at $26.23 with an exceptionally low 1.9% realized volatility. The RISK_ON macro backdrop and ultra-tight credit spreads (OAS 0.76%) provide high conviction that the debt financing for this deal remains highly secure. Consequently, the stock is easily absorbing recent negative headlines regarding legal investigations into past accounting errors, treating them as irrelevant noise.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSPERFECT STACKINSIDE OUT

Key Takeaways

Merger Arbitrage Anchor: TBRG is trading just two cents below its $26.25 cash acquisition price, driving the ultra-low 1.9% volatility and steady accumulation signals.
Noise vs. Signal: Recent legal investigations into delayed 2025 filings are immaterial to the price action, as the definitive M&A agreement supersedes historical accounting issues.
Financing Security: The RISK_ON macro environment and tight credit spreads ensure the bank loans backing the IKS Health deal remain structurally sound ahead of the Q3 2026 close.

← Back to 2026-07-01 View Full TBRG History →Yahoo Finance &nearr;